Profound Medical Corp T.PRN

Alternate Symbol(s): PROF

Healthcare Medical Devices

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

TSX:PRN - Post by User

Profound Medical Corp > christmas gift ...

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Dec 30, 2020 5:24pm

187 Views

Post# 32199944

RE:RE:christmas gift ...

retiredcf wrote: The SP is almost back to where it was at the beginning of the month (and before the TULSA-PRO announcement) so had to add a few more this morning. GLTA

Sounds good. We need some renewed growth activity in the New Year - maybe something big with GE as well ???

Also need some updates on the Sonalleve strategy. Before COvID, there were plans to move forward on a special project in Germany ... with partnership with gov. Maybe a kickstart there and rare disease in USA in 2021.

Good Luck All !!!

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market